Immunobiology of Stiff-Person Syndrome

REFERENCES

• Lang B., Dale R. C., Vincent A. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 2003; 16: 351–357
   PubMed Web of Science ®Google Scholar
• Levy L. M., Dalakas M. C., Floeter M. K. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann. Intern. Med. 1999; 131: 522–530
   PubMedGoogle Scholar
• Raju R., Foote J., Banga J. P., Hall T. R., Padoa C. J., Dalakas M. C., Ortqvist E., Hampe C. S. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J. Immunol. 2005; 175: 7755–7762
   PubMedGoogle Scholar
• Murinson B. B., Vincent A. Stiff-person syndrome: autoimmunity and the central nervous system. CNS. Spectr. 2001; 6: 427–433
   PubMedGoogle Scholar
• Moersch F. P., Woltman H. W. Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome); report of a case and some observations in 13 other cases. Proc. Staff. Meet. Mayo Clin. 1956; 31: 421–427
   PubMed Web of Science ®Google Scholar
• Gordon E. E., Januszko D. M., Kaufman L. A critical survey of stiff-man syndrome. Am. J. Med. 1967; 42: 582–599
   PubMedGoogle Scholar
• Lorish T. R., Thorsteinsson G., Howard F. M. Jr., Stiff-man syndrome updated. Mayo Clin. Proc. 1989; 64: 629–636
   PubMedGoogle Scholar
• Goetz C. G., Klawans H. L. On the mechanism of sudden death in Moersch-Woltman syndrome. Neurology 1983; 33: 930–932
   PubMedGoogle Scholar
• Blum P., Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991; 6: 12–20
   PubMed Web of Science ®Google Scholar
• Solimena M., Folli F., Denis-Donini S., Comi G. C., Pozza G., De Camilli P., Vicari A. M. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N. Engl. J. Med. 1988; 318: 1012–1020
   PubMed Web of Science ®Google Scholar
• Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 1990; 322: 1555–1560
   PubMed Web of Science ®Google Scholar
• Butler M. H., Solimena M., Dirkx R., Jr., Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 1993; 178: 2097–2106
   PubMed Web of Science ®Google Scholar
• Dalakas M. C., Fujii M., Li M., McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000; 55: 1531–1535
   PubMed Web of Science ®Google Scholar
• Fenalti G., Law R. H., Buckle A. M., Langendorf C., Tuck K., Rosado C. J., Faux N. G., Mahmood K., Hampe C. S., Banga J. P., Wilce M., Schmidberger J., Rossjohn J., El Kabbani O., Pike R. N., Smith A. I., Mackay I. R., Rowley M. J., Whisstock J. C. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat. Struct. Mol. Biol. 2007; 14: 280–286
   PubMed Web of Science ®Google Scholar
• Asada H., Kawamura Y., Maruyama K., Kume H., Ding R. G., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S.A 1997; 94: 6496–6499
   PubMed Web of Science ®Google Scholar
• Kash S. F., Johnson R. S., Tecott L. H., Noebels J. L., Mayfield R. D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 14060–14065
   PubMed Web of Science ®Google Scholar
• Patel A. B., de Graaf R. A., Martin D. L., Battaglioli G., Behar K. L. Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo. J. Neurochem. 2006; 97: 385–396
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Tuomi T., Rowley M. J., Knowles W. J., Chen Q. Y., McAnally T., Zimmet P. Z., Mackay I. R. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 1994; 71: 53–59
   PubMedGoogle Scholar
• Daw K., Ujihara N., Atkinson M., Powers A. C. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J. Immunol. 1996; 156: 818–825
   PubMed Web of Science ®Google Scholar
• Bjork E., Velloso L. A., Kampe O., Karlsson F. A. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43: 161–165
   PubMed Web of Science ®Google Scholar
• Hawa M. I., Fava D., Medici F., Deng Y. J., Notkins A. L., De Mattia G., Leslie R. D. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 2000; 23: 228–233
   PubMedGoogle Scholar
• Lohmann T., Londei M., Hawa M., Leslie R. D. Humoral and cellular autoimmune responses in stiff person syndrome. Ann. N. Y. Acad. Sci. 2003; 998: 215–222
   PubMedGoogle Scholar
• Tian J., Olcott A. P., Hanssen L. R., Zekzer D., Middleton B., Kaufman D. L. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice. Immunol. Rev. 1998; 164: 119–127
   PubMedGoogle Scholar
• Dinkel K., Meinck H. M., Jury K. M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 1998; 44: 194–201
   PubMed Web of Science ®Google Scholar
• Levy L. M., Levy-Reis I., Fujii M., Dalakas M. C. Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol. 2005; 62: 970–974
   PubMedGoogle Scholar
• Rakocevic G., Raju R., Dalakas M. C. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch. Neurol. 2004; 61: 902–904
   PubMedGoogle Scholar
• Burns T. M., Phillips L. H., Jones H. R. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology 2005; 64: 399–400
   PubMedGoogle Scholar
• Nemni R., Caniatti L. M., Gironi M., Bazzigaluppi E., De Grandis D. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology 2004; 62: 2101–2102
   PubMedGoogle Scholar
• Vianello M., Tavolato B., Armani M., Giometto B. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum 2003; 2: 77–79
   PubMedGoogle Scholar
• Ramirez-Montealegre D., Chattopadhyay S., Curran T. M., Wasserfall C., Pritchard L., Schatz D., Petitto J., Hopkins D., She J. X., Rothberg P. G., Atkinson M., Pearce D. A. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Neurology 2005; 64: 743–745
   PubMed Web of Science ®Google Scholar
• Manto M. U., Laute M. A., Aguera M., Rogemond V., Pandolfo M., Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann. Neurol. 2007; 61: 544–551
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D., Ruiz-Arguelles A., Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol. Today 1996; 17: 163–164
   PubMedGoogle Scholar
• Wenthold R. J., Skaggs K. K., Reale R. R. Retrograde axonal transport of antibodies to synaptic membrane components. Brain Res. 1984; 304: 162–165
   PubMedGoogle Scholar
• Vicari A. M., Folli F., Pozza G., Comi G. C., Comola M., Canal N., Besana C., Borri A., Tresoldi M., Solimena M. Plasmapheresis in the treatment of stiff-man syndrome. N. Engl. J. Med. 1989; 320: 1499
   PubMed Web of Science ®Google Scholar
• Brashear H. R., Phillips L. H. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 1991; 41: 1588–1592
   PubMedGoogle Scholar
• Hao W., Davis C., Hirsch I. B., Eng L. J., Daniels T., Walsh D., Lernmark A. Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study. J. Neurol. 1999; 246: 731–735
   PubMedGoogle Scholar
• De Camilli P., Thomas A., Cofiell R., Folli F., Lichte B., Piccolo G., Meinck H. M., Austoni M., Fassetta G., Bottazzo G. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J. Exp. Med. 1993; 178: 2219–2223
   PubMed Web of Science ®Google Scholar
• Butler M. H., Hayashi A., Ohkoshi N., Villmann C., Becker C. M., Feng G., De Camilli P., Solimena M. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 2000; 26: 307–312
   PubMedGoogle Scholar
• Sommer C., Weishaupt A., Brinkhoff J., Biko L., Wessig C., Gold R., Toyka K. V. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005; 365: 1406–1411
   PubMed Web of Science ®Google Scholar
• Raju R., Rakocevic G., Chen Z., Hoehn G., Semino-Mora C., Shi W., Olsen R., Dalakas M. C. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006; 129: 3270–3276
   PubMedGoogle Scholar
• Ishizawa K., Komori T., Okayama K., Qin X., Kaneko K., Sasaki S., Iwata M. Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study. Acta Neuropathol. (Berl) 1999; 97: 63–70
   PubMedGoogle Scholar
• Warich-Kirches M., Von Bossanyi P., Treuheit T., Kirches E., Dietzmann K., Feistner H., Wittig H. Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin. Neuropathol. 1997; 16: 214–219
   PubMedGoogle Scholar
• Christadoss P., Dauphinee M. J. Immunotherapy for myasthenia gravis: a murine model. J. Immunol. 1986; 136: 2437–2440
   PubMed Web of Science ®Google Scholar
• Raju R., Zhan W. Z., Karachunski P., Conti-Fine B., Sieck G. C., David C. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis. J. Immunol. 1998; 160: 4169–4174
   PubMed Web of Science ®Google Scholar
• Nepom G. T. Class II antigens and disease susceptibility. Annu. Rev. Med. 1995; 46: 17–25
   PubMed Web of Science ®Google Scholar
• Quinn A., McInerney M., Huffman D., McInerney B., Mayo S., Haskins K., Sercarz E. T cells to a dominant epitope of GAD65 express a public CDR3 motif. Int. Immunol. 2006; 18: 967–979
   PubMedGoogle Scholar
• Nepom G. T., Lippolis J. D., White F. M., Masewicz S., Marto J. A., Herman A., Luckey C. J., Falk B., Shabanowitz J., Hunt D. F., Engelhard V. H., Nepom B. S. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 1763–1768
   PubMed Web of Science ®Google Scholar
• Hummel M., Durinovic-Bello I., Bonifacio E., Lampasona V., Endl J., Fessele S., Then B. F., Trenkwalder C., Standl E., Ziegler A. G. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 1998; 65: 204–208
   PubMedGoogle Scholar
• Schloot N. C., Batstra M. C., Duinkerken G., de Vries R. R., Dyrberg T., Chaudhuri A., Behan P. O., Roep B. O. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J. Autoimmun. 1999; 12: 289–296
   PubMedGoogle Scholar
• Pugliese A., Solimena M., Awdeh Z. L., Alper C. A., Bugawan T., Erlich H. A., De Camilli P., Eisenbarth G. S. Association of HLA-DQB1*0201 with stiff-man syndrome. J. Clin. Endocrinol. Metab 1993; 77: 1550–1553
   PubMed Web of Science ®Google Scholar
• Lohmann T., Hawa M., Leslie R. D., Lane R., Picard J., Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 2000; 356: 31–35
   PubMed Web of Science ®Google Scholar
• Matsuo H., Batocchi A. P., Hawke S., Nicolle M., Jacobson L., Vincent A., Newsom-Davis J., Willcox N. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol. 1995; 155: 3683–3692
   PubMed Web of Science ®Google Scholar
• Nagvekar N., Corlett L., Jacobson L. W., Matsuo H., Chalkley R., Driscoll P. C., Deshpande S., Spack E. G., Willcox N. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. J. Immunol. 1999; 162: 4079–4087
   PubMed Web of Science ®Google Scholar
• Christen U., von Herrath M. G. Infections and autoimmunity—good or bad?. J. Immunol. 2005; 174: 7481–7486
   PubMedGoogle Scholar
• Bach J. F. Infections and autoimmune diseases. J. Autoimmun. 2005; 25: 74–80, Suppl
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., von Herrath M. G., Christen U., Whitton J. L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 2006; 19: 80–94
   PubMed Web of Science ®Google Scholar
• Horwitz M. S., Bradley L. M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 1998; 4: 781–785
   PubMed Web of Science ®Google Scholar
• Kouskoff V., Korganow A. S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996; 87: 811–822
   PubMed Web of Science ®Google Scholar
• Srinivasappa J., Saegusa J., Prabhakar B. S., Gentry M. K., Buchmeier M. J., Wiktor T. J., Koprowski H., Oldstone M. B., Notkins A. L. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol. 1986; 57: 397–401
   PubMed Web of Science ®Google Scholar
• Salloway S., Mermel L. A., Seamans M., Aspinall G. O., Nam Shin J. E., Kurjanczyk L. A., Penner J. L. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect. Immun. 1996; 64: 2945–2949
   PubMed Web of Science ®Google Scholar
• Prendergast M. M., Moran A. P. Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J. Endotoxin. Res. 2000; 6: 341–359
   PubMedGoogle Scholar
• Levin M. C., Lee S. M., Kalume F., Morcos Y., Dohan F. C., Jr., Hasty K. A., Callaway J. C., Zunt J., Desiderio D., Stuart J. M. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 2002; 8: 509–513
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P. L., Dyrberg T., Drachman D. B., Oldstone M. B. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J. Clin. Invest. 1989; 84: 1174–1180
   PubMed Web of Science ®Google Scholar
• Norris S. J. Antigenic variation with a twist—the Borrelia story. Mol. Microbiol. 2006; 60: 1319–1322
   PubMedGoogle Scholar
• Wormser G. P. Clinical practice. Early Lyme disease. N. Engl. J. Med. 2006; 354: 2794–2801
   PubMed Web of Science ®Google Scholar
• Chuenkova M. V., Pereiraperrin M. Enhancement of tyrosine hydroxylase expression and activity by Trypanosoma cruzi parasite-derived neurotrophic factor. Brain Res. 2006; 1099: 167–175
   PubMedGoogle Scholar
• Ercolini A. M., Miller S. D. Role of immunologic cross-reactivity in neurological diseases. Neurol. Res. 2005; 27: 726–733
   PubMed Web of Science ®Google Scholar
• Bachmaier K., Neu N., de la Maza L. M., Pal S., Hessel A., Penninger J. M. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283: 1335–1339
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., Oldstone M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Panoutsakopoulou V., Sanchirico M. E., Huster K. M., Jansson M., Granucci F., Shim D. J., Wucherpfennig K. W., Cantor H. Analysis of the relationship between viral infection and autoimmune disease. Immunity 2001; 15: 137–147
   PubMed Web of Science ®Google Scholar
• James J. A., Neas B. R., Moser K. L., Hall T., Bruner G. R., Sestak A. L., Harley J. B. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001; 44: 1122–1126
   PubMed Web of Science ®Google Scholar
• Amedei A., Bergman M. P., Appelmelk B. J., Azzurri A., Benagiano M., Tamburini C., van der Z. R., Telford J. L., Vandenbroucke-Grauls C. M., D'Elios M. M., Del Prete G. Molecular mimicry between Helicobacter pylori antigens and H+, K+ –adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 2003; 198: 1147–1156
   PubMed Web of Science ®Google Scholar
• Wucherpfennig K. W., Strominger J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705
   PubMed Web of Science ®Google Scholar
• Wucherpfennig K. W. T cell receptor crossreactivity as a general property of T cell recognition. Mol. Immunol 2004; 40: 1009–1017
   PubMedGoogle Scholar
• Jameson S. C., Bevan M. J. T cell receptor antagonists and partial agonists. Immunity 1995; 2: 1–11
   PubMed Web of Science ®Google Scholar
• Tallquist M. D., Weaver A. J., Pease L. R. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J. Immunol. 1998; 160: 802–809
   PubMed Web of Science ®Google Scholar
• Kersh G. J., Allen P. M. Essential flexibility in the T-cell recognition of antigen. Nature 1996; 380: 495–498
   PubMed Web of Science ®Google Scholar
• Garcia K. C., Degano M., Pease L. R., Huang M., Peterson P. A., Teyton L., Wilson I. A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 1998; 279: 1166–1172
   PubMed Web of Science ®Google Scholar
• Hassin-Baer S., Kirson E. D., Shulman L., Buchman A. S., Bin H., Hindiyeh M., Markevich L., Mendelson E. Stiff-person syndrome following West Nile fever. Arch. Neurol. 2004; 61: 938–941
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Bowman M. A., Campbell L., Darrow B. L., Kaufman D. L., Maclaren N. K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest 1994; 94: 2125–2129
   PubMed Web of Science ®Google Scholar
• Hiemstra H. S., Schloot N. C., van Veelen P. A., Willemen S. J., Franken K. L., van Rood J. J., de Vries R. R., Chaudhuri A., Behan P. O., Drijfhout J. W., Roep B. O. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 3988–3991
   PubMed Web of Science ®Google Scholar
• Li L., Hagopian W. A., Brashear H. R., Daniels T., Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 1994; 152: 930–934
   PubMed Web of Science ®Google Scholar
• Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H. J., Turck C. W., Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994; 180: 595–606
   PubMed Web of Science ®Google Scholar
• Petersen J. S., Kulmala P., Clausen J. T., Knip M., Dyrberg T. Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65). Childhood Diabetes in Finland Study Group. Clin. Immunol. 1999; 90: 276–281
   PubMed Web of Science ®Google Scholar
• Dalakas M. C., Li M., Fujii M., Jacobowitz D. M. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001; 57: 780–784
   PubMedGoogle Scholar
• Baekkeskov S., Landin M., Kristensen J. K., Srikanta S., Bruining G. J., Mandrup-Poulsen T., de Beaufort C., Soeldner J. S., Eisenbarth G., Lindgren F. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J. Clin. Invest. 1987; 79: 926–934
   PubMed Web of Science ®Google Scholar